Artgen Biotech PJSC (MOEX:ISKJ)
Russia · Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Ratios and Metrics
Market cap in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,287 | - | 4,401 | 4,419 | 4,287 | 8,272 | |
Market Cap Growth | - | - | -0.41% | 3.10% | -48.18% | 201.10% |
Enterprise Value | 4,936 | - | 5,317 | 5,296 | 5,060 | 8,928 |
Last Close Price | 59.54 | - | 59.54 | 59.54 | 59.54 | 114.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8133.80 | - | 20.48 | 26.17 | 92.95 | 711.21 |
PS Ratio | 2.44 | - | 2.89 | 3.23 | 3.77 | 7.01 |
PB Ratio | 3.01 | - | 4.25 | 4.53 | 7.52 | 17.96 |
P/TBV Ratio | - | - | 214.14 | 17.75 | 22.45 | 77.90 |
P/FCF Ratio | 44.26 | - | 11.52 | 19.17 | 50.80 | 64.88 |
P/OCF Ratio | 16.12 | - | 9.13 | 10.16 | 19.46 | 29.46 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.81 | - | 3.50 | 3.87 | 4.45 | 7.56 |
EV/EBITDA Ratio | 26.14 | - | 15.00 | 16.32 | 36.80 | 47.29 |
EV/EBIT Ratio | 69.16 | - | 17.75 | 19.23 | 51.92 | 68.45 |
EV/FCF Ratio | 50.97 | - | 13.91 | 22.97 | 59.97 | 70.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.71 | 0.85 | 0.71 | 0.81 | 1.46 | 1.34 |
Debt / EBITDA Ratio | 4.95 | 3.77 | 1.92 | 2.27 | 5.51 | 2.94 |
Debt / FCF Ratio | - | 47.41 | 1.93 | 3.41 | 9.86 | 4.84 |
Net Debt / Equity Ratio | 0.18 | 0.21 | 0.19 | 0.22 | 1.06 | 0.92 |
Net Debt / EBITDA Ratio | 1.34 | 1.04 | 0.56 | 0.66 | 4.40 | 2.24 |
Net Debt / FCF Ratio | - | 11.52 | 0.52 | 0.93 | 7.17 | 3.32 |
Asset Turnover | 0.57 | 0.61 | 0.59 | 0.60 | 0.60 | 0.73 |
Inventory Turnover | 2.72 | 3.17 | 2.02 | 1.75 | 1.99 | 1.93 |
Quick Ratio | 1.06 | 1.15 | 1.40 | 1.30 | 0.90 | 0.81 |
Current Ratio | 1.78 | 1.79 | 2.21 | 1.99 | 1.74 | 1.77 |
Return on Equity (ROE) | -0.01% | 9.90% | 24.00% | 25.20% | 4.48% | 7.66% |
Return on Assets (ROA) | 1.95% | 2.93% | 7.23% | 7.50% | 3.22% | 5.02% |
Return on Invested Capital (ROIC) | 5.77% | 10.11% | 24.73% | 21.45% | 7.46% | 15.53% |
Return on Capital Employed (ROCE) | 3.80% | 6.00% | 13.80% | 13.90% | 5.90% | 9.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '22 Jul 7, 2022 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.01% | - | 4.88% | 3.82% | 1.08% | 0.14% |
FCF Yield | 2.26% | - | 8.68% | 5.22% | 1.97% | 1.54% |
Dividend Yield | 2.02% | - | - | 2.02% | 1.68% | - |
Payout Ratio | 12755.22% | 57.97% | 65.46% | 61.72% | - | - |
Buyback Yield / Dilution | - | -0.89% | 19.64% | -6.60% | -8.64% | -6.67% |
Total Shareholder Return | 2.02% | -0.89% | 19.64% | -4.58% | -6.96% | -6.67% |